Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530460 · ClinicalTrials.gov registry record · NA
Comparative Study of High Performance Low-Cost Optical Coherence Tomography
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT05530460: Completed NA study, sponsored by Duke University.
NCT05530460 is a NA study that has completed, run by Duke University. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05530460, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to complete performance testing of our custom optical coherence tomography (OCT) device to verify it can deliver retinal images of similar quality to a commercial OCT device.
Primary Outcome
measured by: ability to see clearly defined and recognizable structures of the retina with the low-cost OCT device.
Interventions
- DEVICE retinal imaging with low-cost OCT device
- DEVICE retinal imaging with commercial OCT device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-03-22 |
| Est. Completion | 2024-05-17 |
| Phase | NA |
What the finished NCT05530460 record still lists
NCT05530460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which retinal imaging with low-cost OCT device is the first listed.
NCT05530460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05530460 about?
NCT05530460 is a clinical study titled "Comparative Study of High Performance Low-Cost Optical Coherence Tomography". The purpose of this study is to complete performance testing of our custom optical coherence tomography (OCT) device to verify it can deliver retinal images of similar quality to a commercial OCT device.
What is the current status of trial NCT05530460?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2024-03-22. Estimated completion is 2024-05-17.
What interventions are being tested in trial NCT05530460?
The interventions under investigation include: retinal imaging with low-cost OCT device (DEVICE), retinal imaging with commercial OCT device (DEVICE).
Who is sponsoring clinical trial NCT05530460?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05530460's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI